Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?
Nutt et al.
J Psychopharmacol 2012;26:199-204.
FULL TEXT
Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study
Caputo et al.
J Psychopharmacol 2009;23:883-890.
ABSTRACT
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel
Physiol. Rev. 2009;89:649-705.
ABSTRACT
| FULL TEXT
Effect of Naltrexone and Ondansetron on Alcohol Cue-Induced Activation of the Ventral Striatum in Alcohol-Dependent People
Myrick et al.
Arch Gen Psychiatry 2008;65:466-475.
ABSTRACT
| FULL TEXT
Prospects for a Genomic Approach to the Treatment of Alcoholism
O'Brien
Arch Gen Psychiatry 2008;65:132-133.
FULL TEXT
Longitudinal Course of Substance Treatment Benefits in Older Male Veteran At-Risk Drinkers
Zanjani et al.
J Gerontol A Biol Sci Med Sci 2008;63:98-106.
ABSTRACT
| FULL TEXT
Future of God in Recovery from Drug Addiction
Sellman et al.
Aust N Z J Psychiatry 2007;41:800-808.
ABSTRACT
| FULL TEXT
Effects of Naltrexone on Alcohol Sensitivity and Genetic Moderators of Medication Response: A Double-blind Placebo-Controlled Study
Ray and Hutchison
Arch Gen Psychiatry 2007;64:1069-1077.
ABSTRACT
| FULL TEXT
Varenicline, an {alpha}4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking
Steensland et al.
Proc. Natl. Acad. Sci. USA 2007;104:12518-12523.
ABSTRACT
| FULL TEXT
Association of a Functional Polymorphism in the {micro}-Opioid Receptor Gene With Alcohol Response and Consumption in Male Rhesus Macaques
Barr et al.
Arch Gen Psychiatry 2007;64:369-376.
ABSTRACT
| FULL TEXT
Emerging approaches to managing alcohol dependence
SWIFT
Am J Health Syst Pharm 2007;64:S12-S22.
ABSTRACT
| FULL TEXT
Presynaptic {delta} Opioid Receptors Regulate Ethanol Actions in Central Amygdala
Kang-Park et al.
J. Pharmacol. Exp. Ther. 2007;320:917-925.
ABSTRACT
| FULL TEXT
Psychotic Spectrum Disorders and Alcohol Abuse: A Review of Pharmacotherapeutic Strategies and a Report on the Effectiveness of Naltrexone and Disulfiram
Petrakis et al.
Schizophr Bull 2006;32:644-654.
ABSTRACT
| FULL TEXT
COMBINED ACAMPROSATE AND NALTREXONE, WITH COGNITIVE BEHAVIOURAL THERAPY IS SUPERIOR TO EITHER MEDICATION ALONE FOR ALCOHOL ABSTINENCE: A SINGLE CENTRES' EXPERIENCE WITH PHARMACOTHERAPY
FEENEY et al.
Alcohol Alcohol 2006;41:321-327.
ABSTRACT
| FULL TEXT
Association between two {micro}-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence
Zhang et al.
Hum Mol Genet 2006;15:807-819.
ABSTRACT
| FULL TEXT
Long acting injectable naltrexone is effective and safe for treating alcohol dependence
Killeen
Evid. Based Ment. Health 2005;8:100-100.
FULL TEXT
Pharmacokinetics of Long-Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment
Turncliff et al.
J Clin Pharmacol 2005;45:1259-1267.
ABSTRACT
| FULL TEXT
Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats
Perfumi et al.
J Psychopharmacol 2005;19:448-454.
ABSTRACT
Review: naltrexone reduces alcohol consumption (in the short-term) in patients with alcohol dependence
Graham
Evid. Based Med. 2005;10:120-120.
FULL TEXT
EFFECT OF COMMUNITY NURSE FOLLOW-UP WHEN TREATING ALCOHOL DEPENDENCE WITH ACAMPROSATE
PELC et al.
Alcohol Alcohol 2005;40:302-307.
ABSTRACT
| FULL TEXT
EFFECTS OF NALTREXONE ON THE ETHANOL-INDUCED CHANGES IN THE RAT CENTRAL DOPAMINERGIC SYSTEM
LEE et al.
Alcohol Alcohol 2005;40:297-301.
ABSTRACT
| FULL TEXT
CLINICAL PREDICTORS OF RESPONSE TO NALTREXONE IN ALCOHOLIC PATIENTS: WHO BENEFITS MOST FROM TREATMENT WITH NALTREXONE?
RUBIO et al.
Alcohol Alcohol 2005;40:227-233.
ABSTRACT
| FULL TEXT
Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence: A Randomized Controlled Trial
Garbutt et al.
JAMA 2005;293:1617-1625.
ABSTRACT
| FULL TEXT
Alcohol Dependence: The Impact of Cognitive Behaviour Therapy with or Without Naltrexone on Subjective Health Status
Feeney et al.
Aust N Z J Psychiatry 2004;38:842-848.
ABSTRACT
| FULL TEXT
Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
PHARMACOTHERAPEUTIC TRIALS IN ADOLESCENT ALCOHOL USE DISORDERS: OPPORTUNITIES AND CHALLENGES
Dawes and Johnson
Alcohol Alcohol 2004;39:166-177.
ABSTRACT
| FULL TEXT
Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
Chick et al.
J Psychopharmacol 2003;17:397-402.
ABSTRACT
Initial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care: A Nested Sequence of 3 Randomized Trials
O'Malley et al.
Arch Intern Med 2003;163:1695-1704.
ABSTRACT
| FULL TEXT
Acamprosate for the Adjunctive Treatment of Alcohol Dependence
Overman et al.
The Annals of Pharmacotherapy 2003;37:1090-1099.
ABSTRACT
| FULL TEXT
COMPARISON OF CYANAMIDE AND PLACEBO IN THE TREATMENT OF ALCOHOL DEPENDENCE OF ADOLESCENTS
Niederhofer et al.
Alcohol Alcohol 2003;38:50-53.
ABSTRACT
| FULL TEXT
Comparing and Combining Naltrexone and Acamprosate in Relapse Prevention of Alcoholism: A Double-blind, Placebo-Controlled Study
Kiefer et al.
Arch Gen Psychiatry 2003;60:92-99.
ABSTRACT
| FULL TEXT
NEUROCHEMICAL MARKERS OF ALCOHOLISM VULNERABILITY IN HUMANS
Ratsma et al.
Alcohol Alcohol 2002;37:522-533.
ABSTRACT
| FULL TEXT
DOES PSYCHOSOCIAL TREATMENT ENHANCE THE EFFICACY OF ACAMPROSATE IN PATIENTS WITH ALCOHOL PROBLEMS?
de Wildt et al.
Alcohol Alcohol 2002;37:375-382.
ABSTRACT
| FULL TEXT
Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges
Weiss and Porrino
J. Neurosci. 2002;22:3332-3337.
ABSTRACT
| FULL TEXT
SHORT-TERM METHADONE ADMINISTRATION REDUCES ALCOHOL CONSUMPTION IN NON-ALCOHOLIC HEROIN ADDICTS
Caputo et al.
Alcohol Alcohol 2002;37:164-168.
ABSTRACT
| FULL TEXT
NALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Streeton and Whelan
Alcohol Alcohol 2001;36:544-552.
ABSTRACT
| FULL TEXT
NALTREXONE VERSUS ACAMPROSATE: ONE YEAR FOLLOW-UP OF ALCOHOL DEPENDENCE TREATMENT
Rubio et al.
Alcohol Alcohol 2001;36:419-425.
ABSTRACT
| FULL TEXT
Outpatient Cognitive Behavioural Therapy Programme for Alcohol Dependence: Impact of Naltrexone Use on Outcome
Feeney et al.
Aust N Z J Psychiatry 2001;35:443-448.
ABSTRACT
| FULL TEXT
Pharmacogenetics of Alcohol Response and Alcoholism: The Interplay of Genes and Environmental Factors in Thresholds for Alcoholism
Radel and Goldman
Drug Metab. Dispos. 2001;29:489-494.
ABSTRACT
| FULL TEXT
Addiction and the brain: the role of neurotransmitters in the cause and treatment of drug dependence
Tomkins and Sellers
CMAJ 2001;164:817-821.
ABSTRACT
| FULL TEXT
Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism
Sinclair
Alcohol Alcohol 2001;36:2-10.
ABSTRACT
| FULL TEXT
Outpatient Management of Patients with Alcohol Problems
Fiellin et al.
ANN INTERN MED 2000;133:815-827.
ABSTRACT
| FULL TEXT
A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NALTREXONE IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ABUSE
Chick et al.
Alcohol Alcohol 2000;35:587-593.
ABSTRACT
| FULL TEXT
Drug Dependence, a Chronic Medical Illness: Implications for Treatment, Insurance, and Outcomes Evaluation
McLellan et al.
JAMA 2000;284:1689-1695.
ABSTRACT
| FULL TEXT
THE LONG-TERM COST-EFFECTIVENESS OF IMPROVING ALCOHOL ABSTINENCE WITH ADJUVANT ACAMPROSATE
Palmer et al.
Alcohol Alcohol 2000;35:478-492.
ABSTRACT
| FULL TEXT
Naltrexone plus cognitive behavioural therapy led to fewer drinking relapses in outpatients with alcoholism
Chick
Evid. Based Ment. Health 2000;3:75-75.
FULL TEXT
{micro}-Opioid Receptor Knockout Mice Do Not Self-Administer Alcohol
Roberts et al.
J. Pharmacol. Exp. Ther. 2000;293:1002-1008.
ABSTRACT
| FULL TEXT
Novel Uncompetitive N-Methyl-D-Aspartate (NMDA)-Receptor Antagonist MRZ 2/579 Suppresses Ethanol Intake in Long-Term Ethanol-Experienced Rats and Generalizes to Ethanol Cue in Drug Discrimination Procedure
Holter et al.
J. Pharmacol. Exp. Ther. 2000;292:545-552.
ABSTRACT
| FULL TEXT
Oral nalmefene reduced relapse to heavy drinking and was well tolerated in patients with alcohol dependence
Chick
Evid. Based Ment. Health 2000;3:20-20.
FULL TEXT
TRAIT MARKERS FOR ALCOHOLISM: CLINICAL UTILITY
Farren and Tipton
Alcohol Alcohol 1999;34:649-665.
ABSTRACT
| FULL TEXT
A Double-blind, Placebo-Controlled Study of Oral Nalmefene for Alcohol Dependence
Mason et al.
Arch Gen Psychiatry 1999;56:719-724.
ABSTRACT
| FULL TEXT
Opioids, Reward and Addiction: An Encounter of Biology, Psychology, and Medicine
van Ree et al.
Pharmacol. Rev. 1999;51:341-396.
ABSTRACT
| FULL TEXT
Role of the Primary Care Physician in Problems of Substance Abuse
Weaver et al.
Arch Intern Med 1999;159:913-924.
ABSTRACT
| FULL TEXT
PERSONALITY AND ALCOHOL/SUBSTANCE-USE DISORDER PATIENT RELAPSE AND ATTENDANCE AT SELF-HELP GROUP MEETINGS
Janowsky et al.
Alcohol Alcohol 1999;34:359-369.
ABSTRACT
| FULL TEXT
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt et al.
JAMA 1999;281:1318-1325.
ABSTRACT
| FULL TEXT
Naltrexone (ReVia)
Australas Psychiatry 1999;7:106-106.
ABSTRACT
| FULL TEXT
Suppression of Ethanol-Reinforced Behavior by Naltrexone Is Associated with Attenuation of the Ethanol-Induced Increase in Dialysate Dopamine Levels in the Nucleus Accumbens
Gonzales and Weiss
J. Neurosci. 1998;18:10663-10671.
ABSTRACT
| FULL TEXT
Family History of Alcoholism and Hypothalamic Opioidergic Activity
Wand et al.
Arch Gen Psychiatry 1998;55:1114-1119.
ABSTRACT
| FULL TEXT
Contribution of the Opioid System to Alcohol Aversion and Alcohol Drinking Behavior
Froehlich et al.
J. Pharmacol. Exp. Ther. 1998;287:284-292.
ABSTRACT
| FULL TEXT
The Effect of Depression on Return to Drinking: A Prospective Study
Greenfield et al.
Arch Gen Psychiatry 1998;55:259-265.
ABSTRACT
| FULL TEXT
Drug Development for Disorders of the Nervous System: Challenge and Opportunity at the Pharmaceutical-Biotech-Academic Interface
Schmidt
Neuroscientist 1998;4:9-13.
ABSTRACT
The Safety Profile of Naltrexone in the Treatment of Alcoholism: Results From a Multicenter Usage Study
Croop et al.
Arch Gen Psychiatry 1997;54:1130-1135.
ABSTRACT
{blacktriangledown}Acamprosate for alcohol dependence?
DTB 1997;35:70-72.
ABSTRACT
| FULL TEXT
Naltrexone and Alcohol Dependence: Role of Subject Compliance
Volpicelli et al.
Arch Gen Psychiatry 1997;54:737-742.
ABSTRACT
Addiction Medicine
O'Brien and McLellan
JAMA 1997;277:1840-1841.
Daidzin inhibits mitochondrial aldehyde dehydrogenase and suppresses ethanol intake of Syrian golden hamsters
Keung et al.
Proc. Natl. Acad. Sci. USA 1997;94:1675-1679.
ABSTRACT
| FULL TEXT
What is the Psychiatrist's Role in Drugs and Alcohol?
Pols et al.
Aust N Z J Psychiatry 1996;30:540-548.
ABSTRACT
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass et al.
Arch Gen Psychiatry 1996;53:673-680.
ABSTRACT
Addiction Medicine
Wesson and Ling
JAMA 1996;275:1792-1793.
ABSTRACT
Mental Disorders and Homicidal Behavior in Finland
Eronen et al.
Arch Gen Psychiatry 1996;53:497-501.
ABSTRACT
A Double-blind, Placebo-Controlled Trial of Desipramine for Primary Alcohol Dependence Stratified on the Presence or Absence of Major Depression
Mason et al.
JAMA 1996;275:761-767.
ABSTRACT
Alcohol Research: At the Cutting Edge
Gordis
Arch Gen Psychiatry 1996;53:199-201.
ABSTRACT
Six-Month Follow-up of Naltrexone and Psychotherapy for Alcohol Dependence
O'Malley et al.
Arch Gen Psychiatry 1996;53:217-224.
ABSTRACT
The Obsessive Compulsive Drinking Scale: A New Method of Assessing Outcome in Alcoholism Treatment Studies
Anton et al.
Arch Gen Psychiatry 1996;53:225-231.
ABSTRACT
Enhanced Sensitivity of Pituitary {beta}Endorphin to Ethanol in Subjects at High Risk of Alcoholism
Gianoulakis et al.
Arch Gen Psychiatry 1996;53:250-257.
ABSTRACT
Addiction Medicine
Franklin
JAMA 1993;270:184-185.
ABSTRACT
